Tiffany Bland
Family Medicine · Saint James, MONPI 1447755848
Payments from drug & device makers
Across 182 payments — averaging $19.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$575
- AbbVie$507
- Amgen$475
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$385
- Lilly USA, LLC$229
- Otsuka America Pharmaceutical, Inc.$200
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,563100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 30 | $575 |
| AbbVie | 24 | $507 |
| Amgen | 24 | $475 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 23 | $385 |
| Lilly USA, LLC | 10 | $229 |
| Otsuka America Pharmaceutical, Inc. | 11 | $200 |
| AstraZeneca | 11 | $169 |
| Lundbeck LLC | 7 | $143 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $140 |
| Axsome Therapeutics, Inc. | 2 | $107 |
| Merck | 5 | $85 |
| Sanofi-aventis U.S. LLC | 1 | $70 |
| Pfizer | 4 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| GSK | 3 | $44 |
| Abbott | 2 | $40 |
| Organon | 3 | $36 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $33 |
| Exact Sciences | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| Avanir Pharmaceuticals, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $21 |
| Bayer | 1 | $20 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
| Viatris Specialty LLC | 1 | $19 |
| Ardelyx, Inc. | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Boston Scientific | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$115
How this compares
$3,563 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 74 | $76,295 |
| FarxigaDapagliflozin Propanediol | 73 | $50,196 |
| MounjaroTirzepatide | 32 | $38,442 |
| TrulicityDulaglutide | 25 | $24,543 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $20,541 |
| EliquisApixaban | 34 | $20,530 |
| JanumetSitagliptin Phos/Metformin Hcl | 24 | $19,378 |
| JardianceEmpagliflozin | 22 | $16,340 |
| XareltoRivaroxaban | 28 | $16,179 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $10,402 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $6,453 |
| Spiriva HandihalerTiotropium Bromide | 11 | $5,758 |
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 25 | $5,637 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 43 | $5,470 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 24 | $5,037 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $575 | $76,29574 claims |
| Lilly USA, LLCMounjaro, Trulicity | $229 | $62,98557 claims |
| AstraZenecaFarxiga | $169 | $50,19673 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $44 | $26,99541 claims |
| MerckJanumet, Janumet Xr | $85 | $24,41548 claims |
| PfizerEliquis | $60 | $20,53034 claims |
| Johnson & JohnsonXarelto | $21 | $16,17928 claims |
| Sanofi-aventis U.S. LLCLantus | $70 | $2,02914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Saint James
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.